Start-up Application

Advanced Therapies USA 2024 will play host to 50 start-ups from across the ATMP space, working on cutting edge cell and gene therapies, innovative platform technologies and pioneering AI and machine learning solutions. This introductory offer is a unique opportunity to exhibit, network and pitch to our global audience of pharma, biotech, and investment professionals. If you’re a start-up in the cell and gene therapy industry, apply now to secure your place in our Start-up Zone!

To qualify for this, offer your company must have been established in the last 5 years, have fewer than 50 employees and have received no more than series B funding.

Apply below